Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Hankerchiefon Jul 09, 2020 1:34pm

130 Views

Post# 31246419

RE:RE:Anonymous = Pharma??????????????

Fred, If they could get the TLD 1433 IV + xray activation studies going then that would open the floodgates to treating all kinds of cancer IMO. Can't believe during this coarona thing they have'nt been making advances on it. Need an IV, a few willing pigs, some TLD 1433, xray. Mix together for safety data. Then human trials. People are dying. Shruggs.

fredgoodwinson wrote:
If you read Eog`s find thoroughly (link below) you’ll see that TLD-1433 looks like the goods and within 18 months could be in lung (NSCLC and/or mesothelioma) brain and bladder in humans:

https://www.mdpi.com/1424-8247/13/7/137/htm

Has Sherri found it necessary to independently open a second front for her exceptional photosensitiser TLD-1433 because of the failure of our Management to do this themselves or are TLT quietly perfecting something very special with Rutherrin and X-ray?? - possibly both.

The Company has no debt but is being given no hope value either despite the recent news that development of TLD-1433 for a major indication - and in fact the biggest of all - is being undertaken by the pre-eminent US Centre for PDT without costing Theralase a cent.

Keep picking them up at these levels when I can.